Corporate Profile
Web Site:
Registration country:
United States
Overview
Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. Our founding team has a successful track record starting companies and building dedicated teams to develop new drug products that improve patients' lives. At Elevation, we have a disciplined approach to strategic decision-making that helps us stay focused on the path with the highest probability of success. We are executing our drug development plans with passion, integrity, and a high sense of urgency in order to meet the needs and expectations of our stakeholders -- employees, investors, partners, and patients.
Investors
| Investor | Profile | Amount | Stage | Date | ||
|---|---|---|---|---|---|---|
| Canaan Partners | Venture capital firm with a focus on early stage technology and healthcare companies | Sep 2011 | ||||
| Canaan Partners | Venture capital firm with a focus on early stage technology and healthcare companies | USD | Series B | Jan 2012 | ||
| Care Capital LLC | USD | Series A | Sep 2011 | |||
| Care Capital LLC | USD | Series B | Jan 2012 | |||
| Mesa Verde Venture Partners | USD | Series A | Sep 2011 | |||
| Mesa Verde Venture Partners | USD | Series B | Jan 2012 | |||
| Novo Ventures (US) Inc | USD | Series B | Jan 2012 | |||
| TPG Biotechnology Partners LP | USD | Series B | Jan 2012 | |||
| TPG Capital LP | One of the world's largest private equity firms | USD | Series A | Sep 2011 | ||
| TPG Growth |
Current employees
No current employees available
RECORD ID: 111321